Avalyn Pharma Inc.
AVLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540171
No open-market purchases or sales by Avalyn Pharma Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $1.46B in total; Soros Fund Management is the only superinvestor holding it.
Members of Congress who traded AVLN
No member of Congress has reported a trade in Avalyn Pharma Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.